Dr Jennifer M Burstain, MD | |
1911 1st Ave Se, Cedar Rapids, IA 52402-5320 | |
(319) 366-1503 | |
(319) 366-6976 |
Full Name | Dr Jennifer M Burstain |
---|---|
Gender | Female |
Speciality | Counselor |
Location | 1911 1st Ave Se, Cedar Rapids, Iowa |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477666485 | NPI | - | NPPES |
0258749 | Medicaid | IA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 33047 (Iowa) | Secondary |
101Y00000X | Counselor | (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Jennifer M Burstain, MD 999 164th Ave Ne, Bellevue, WA 98008-3518 Ph: (425) 586-2338 | Dr Jennifer M Burstain, MD 1911 1st Ave Se, Cedar Rapids, IA 52402-5320 Ph: (319) 366-1503 |
News Archive
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Acarbose Tablets, 25 mg, 50 mg and 100 mg, the generic version of Bayer's Precose® Tablets, a treatment to be used with diet and exercise to improve glycemic control in adults with type 2 diabetes.
Increasing the levels of the anti-aging protein hormone Klotho improves the neurological deficits and prolongs life span in an experimental model with Amyotrophic Lateral Sclerosis.
A unique new imaging method, called "polarized nuclear imaging" - combining powerful aspects of both magnetic resonance imaging and gamma-ray imaging and developed by two physicists in the University of Virginia's departments of Physics and Radiology- has potential for new types of high-resolution medical diagnostics as well as industrial and physics research applications.
The bill rushed through the House of Representatives by voice vote yesterday to patch Medicare regulations includes a highly controversial provision that has nothing to do with Medicare, and that would subject people in crisis to forced treatment.
A consortium of 18 partners embarks on the development of a lab-on-a-chip to detect Alzheimer´s disease and similar diseases in the brain. The project is funded by the EU´s 7th Framework programme for nanotechnology.
› Verified 8 days ago